460 related articles for article (PubMed ID: 19939747)
1. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
3. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia.
Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N
J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
6. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
7. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
9. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
[TBL] [Abstract][Full Text] [Related]
10. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
12. Predictors of mortality in adults with cystic fibrosis.
Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
[TBL] [Abstract][Full Text] [Related]
13. A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines.
Mantovani RP; Levy CE; Yano T
J Cyst Fibros; 2012 Jul; 11(4):305-11. PubMed ID: 22440828
[TBL] [Abstract][Full Text] [Related]
14. Emerging and unusual gram-negative infections in cystic fibrosis.
Davies JC; Rubin BK
Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults.
Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS
J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
Watt AP; Courtney J; Moore J; Ennis M; Elborn JS
Thorax; 2005 Aug; 60(8):659-64. PubMed ID: 16061707
[TBL] [Abstract][Full Text] [Related]
18. Differential cytokine profile in children with cystic fibrosis.
Brazova J; Sediva A; Pospisilova D; Vavrova V; Pohunek P; Macek M; Bartunkova J; Lauschmann H
Clin Immunol; 2005 May; 115(2):210-5. PubMed ID: 15885645
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
Moser C; Jensen PØ; Pressler T; Frederiksen B; Lanng S; Kharazmi A; Koch C; Høiby N
APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157
[TBL] [Abstract][Full Text] [Related]
20. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study.
Rønne Hansen C; Pressler T; Høiby N; Gormsen M
J Cyst Fibros; 2006 Dec; 5(4):245-51. PubMed ID: 16777495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
